Search

everythinglearnresearchcommunity

for

Search:↓

Higher CRP levels suggest chronic inflammation is linked to bladder-related urinary symptoms in men with enlarged prostates.

The AA-IGA scale reliably measures treatment success in alopecia areata by considering both clinician and patient views.

SMR-2 and SMR-6 are much more toxic than retinoic acid, causing severe side effects.

A scale was made to measure hair loss severity in African American women.

Non-blinded assessors tend to overestimate effects in trials by about 29%.

People with severe hair loss (Alopecia Areata) have different scalp bacteria than healthy people, which might help predict the condition's progress.

The study found no significant difference in stress hormone levels between people with alopecia areata and healthy individuals, suggesting that the disease is not caused by an overactive stress response system.

Non-coding RNA boosts retinoic acid production and signaling, aiding regeneration.

The procedure reliably measures cortisol in rhesus macaque hair.

Men with early balding may have a higher risk of prostate issues, and surgery for prostate cancer has a slight survival benefit over radiation.

Patients and clinicians generally agree on eyebrow and eyelash hair loss improvements in severe alopecia areata.

A reliable method was developed to measure aristolochic acid-I in rat blood.

A new tool simplifies alopecia areata severity scoring but needs validation.

Young men with early hair loss and high SAA3 levels are at higher risk for heart disease.

SRD5A2 methylation in blood can predict how well someone will respond to finasteride treatment.

SMR-2 and SMR-6 are much more toxic than retinoic acid, causing severe symptoms and organ damage in mice.

Higher RBP4 levels found in people with two types of hair loss.

AGA patients have fewer hairs and smaller follicles; T:V ratio above 4:1 may indicate AGA.

People with ankylosing spondylitis in Taiwan don't have a higher chance of getting alopecia.

Baldness at age 40 is not linked to a higher risk of aggressive prostate cancer.

Hair specialists vary in testing for alopecia areata, highlighting the need for standard guidelines.

Higher MPV and CRP levels may indicate more severe alopecia areata.

Higher Claudin 3 levels in the blood are linked to more severe alopecia areata.

Alopecia Areata patients experience higher social appearance anxiety due to visible hair loss.

Two specific genetic markers increase the risk of hair loss in Asian populations.

High CRP levels could indicate vitamin D deficiency in people with alopecia areata.

Higher NLR, PLR, and MPV may help diagnose androgenetic alopecia.

Asthma may increase the risk of alopecia areata.

Calprotectin levels are higher in alopecia areata patients, indicating systemic inflammation.